Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 05:54:47 +0200Wed, 26 Jun 2024 15:10:00 +0200Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Date of authorisation: 19/02/2009, Revision: 25, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/valdoxanHuman medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Date of authorisation: 19/02/2009, Revision: 25, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/valdoxanWed, 26 Jun 2024 15:10:00 +0200Human medicineValdoxan-H-C-PSUSA-00000071-201502: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500199675_en.pdfValdoxan-H-C-PSUSA-00000071-201502: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500199675_en.pdfTue, 12 Jan 2016 01:00:00 +0100Human medicine